ICON Public Limited Company
ICLR
주식 순위
#1651
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
주가
$168.25
마지막 동기화: 2026-10-16
시가총액
$12.98B
변동 (1일)
-3.93%
변동 (1년)
-9.08%
국가
IE
거래 ICON Public Limited Company (ICLR)
카테고리
Healthcare
ICON Public Limited Company (ICLR)의 영업이익률
October 2026 기준 영업이익률 TTM: 10.15%
ICON Public Limited Company의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 10.15%입니다. 2023년 말 기준 영업이익률은 11.78%였습니다.
ICON Public Limited Company의 영업이익률 기록 (2001 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 10.15% | -23.45% |
| 2024 | 13.26% | 12.56% |
| 2023 | 11.78% | 14.70% |
| 2022 | 10.27% | 48.63% |
| 2021 | 6.91% | -50.64% |
| 2020 | 14.00% | -9.39% |
| 2019 | 15.45% | 7.44% |
| 2018 | 14.38% | -25.26% |
| 2017 | 19.24% | 2.89% |
| 2016 | 18.70% | 4.59% |
| 2015 | 17.88% | 32.84% |
| 2014 | 13.46% | 48.40% |
| 2013 | 9.07% | 39.54% |
| 2012 | 6.50% | 56.63% |
| 2011 | 4.15% | -59.43% |
| 2010 | 10.23% | -15.52% |
| 2009 | 12.11% | 5.30% |
| 2008 | 11.50% | 4.74% |
| 2007 | 10.98% | 4.57% |
| 2006 | 10.50% | 83.57% |
| 2005 | 5.72% | -50.60% |
| 2004 | 11.58% | 4.89% |
| 2003 | 11.04% | -5.07% |
| 2002 | 11.63% | 22.04% |
| 2001 | 9.53% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 17.97% | -98.23% |
US
|
|
| 20.42% | -97.99% |
US
|
|
| -10.70% | -101.05% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -97.81% |
US
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.